US drugmaker reports promising early results from COVID-19 vaccine test

The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people who received it similar to that seen in people convalescing from the virus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2X9hVIb
via IFTTT